Prorenin has high affinity multiple binding sites for (pro)renin receptor

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 12, 2009, Pages 1838-1847

  Nabi, A H M Nurun ^a   Biswas, Kazal Boron ^a   Nakagawa, Tsutomu ^a   Ichihara, Atsuhiro ^b   Inagami, Tadashi ^c   Suzuki, Fumiaki ^a  

^a GIFU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

"Hinge" peptide; Decoy peptide; Human (pro)renin receptor; Prorenin; Renin

Indexed keywords

ANTIBODY; PEPTIDE; PEPTIDE DERIVATIVE; PRORENIN; PRORENIN RECEPTOR; RECOMBINANT PROTEIN; RENIN;

ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOSENSOR; DISSOCIATION CONSTANT; KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; HUMANS; KINETICS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; RENIN;

EID: 73049099445     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.08.024     Document Type: Article

References (36)

1. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., and Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109 (2002) 1417-1427
2. Nurun N.A., Uddin M.N., Nakagawa T., Iwata H., Ichihara A., Inagami T., and Suzuki F. Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front. Biosci. 12 (2007) 4810-4817
3. Batenburg W.W., Krop M., Garrelds I.M., de Vries R., de Bruin R.J., Burcklé C.A., Müller D.N., Bader M., Nguyen G., and Danser A.H. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J. Hypertens. 25 (2007) 2441-2453
4. Nabi A.H., Kageshima A., Uddin M.N., Nakagawa T., Park E.Y., and Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int. J. Mol. Med. 18 (2006) 483-488
5. Burcklé C., and Bader M. Prorenin and its ancient receptor. Hypertension 48 (2006) 549-551
6. Huang Y., Noble N.A., Zhang J., Xu C., and Border W.A. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 72 (2007) 45-52
7. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., and Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 69 (2006) 105-113
8. Shan Z., Cuadra A.E., Sumners C., and Raizada M.K. Characterization of a functional (pro)renin receptor in rat brain neurons. Exp. Physiol. 93 (2008) 701-708
9. Satofuka S., Ichihara A., Nagai N., Tsubota K., Itoh H., and Ishida S. Pathologic roles of prorenin and (pro)renin receptor in the eye. Front. Biosci. 13 (2008) 3884-3895
10. Schefe J.H., Menk M., Reinemund J., Effertz K., Hobbs R.M., Pandolfi P.P., Ruiz P., Unger T., and Funke-Kaiser H. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ. Res. 99 (2006) 1155-1166
11. Sakoda M., Ichihara A., Kaneshiro Y., Takemitsu T., Nakazato Y., Nabi A.H., Nakagawa T., Suzuki F., Inagami T., and Itoh H. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens. Res. 30 (2007) 1139-1146
12. Suzuki F., Hayakawa M., Nakagawa T., Nasir U.M., Ebihara A., Iwasawa A., Ishida Y., Nakamura Y., and Murakami K. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J. Biol. Chem. 278 (2003) 22217-22222
13. Ichihara A., Hayashi M., Kaneshiro Y., Suzuki F., Nakagawa T., Tada Y., Koura Y., Nishiyama A., Okada H., Uddin M.N., Nabi A.H., Ishida Y., Inagami T., and Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J. Clin. Invest. 114 (2004) 1128-1135
14. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Nakagawa T., Nishiyama A., Kawachi H., Shimizu F., and Inagami T. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J. Am. Soc. Nephrol. 17 (2006) 2495-2503
15. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Suzuki F., Nakagawa T., Nishiyama A., Inagami T., and Hayashi M. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 47 (2006) 894-900
16. Satofuka S., Ichihara A., Nagai N., Yamashiro K., Koto T., Shinoda H., Noda K., Ozawa Y., Inoue M., Tsubota K., Suzuki F., Oike Y., and Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2686-2692
17. Susic D., Zhou X., Frohlich E.D., Lippton H., and Knight M. Cardiovascular effects of prorenin blockade in genetically hypertensive rats (SHR) on normal and high salt diet. Am. J. Physiol. Heart. Circ. Physiol. 295 (2008) H1117-H1121
18. He M., Zhang L., Shao Y., Wang X., Huang Y., Yao T., and Lu L. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur. J. Pharmacol. 606 (2009) 155-161
19. Nabi A.H.M.N., Biswas K.B., Nakagawa T., Ichihara A., Ianagami T., and Suzuki F. "Decoy peptide" region (RIFLKRMPSI) of prorenin prosegment plays a crucial role in prorenin binding to the (pro)renin receptor. Int. J. Mol. Med. 24 (2009) 83-89
20. Kim J.K., Tsen M.F., Ghetie V., and Ward E.S. Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule. Mol. Immunol. 32 (1995) 467-475
21. Deeb A., Jääskeläinen J., Dattani M., Whitaker H.C., Costigan C., and Hughes I.A. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions. J. Clin. Endocrinol. Metab. 93 (2008) 3691-3696
22. Sielecki A.R., Hayakawa K., Fujinaga M., Murphy M.E., Fraser M., Muir A.K., Carilli C.T., Lewicki J.A., Baxter J.D., and James M.N. Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution. Science 243 (1989) 1346-1351
23. Imai T., Miyazaki H., Hirose S., Hori H., Hayashi T., Kageyama R., Ohkubo H., Nakanishi S., and Murakami K. Cloning and sequence analysis of cDNA for human renin precursor. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 7405-7409
24. Kato T., Kageshima A., Suzuki F., and Park E.Y. Expression and purification of human (pro)renin receptor in insect cells using baculovirus expression system. Prot. Expr. Purif. 58 (2008) 242-248
25. Nakagawa T., Nishiuchi K., Akaki J., Iwata H., Satou R., Suzuki F., and Nakamura Y. Efficient production of recombinant human (pro)renin utilizing a decahistidine tag attached at the C-terminus. Biosci. Biotechnol. Biochem. 71 (2007) 256-260
26. Suzuki F., Yamashita S., Takahashi A., Ito M., Miyazaki S., Nagata Y., and Nakamura Y. Highly sensitive microplate-ELISA for angiotensin I using 3,3′, 5,5′-tetramethylbenzidine. Clin. Exp. Hypertens. A. 12 (1990) 83-95
27. Nagase M., Suzuki F., Sawai Y., Orihashi T., Inui Y., Nakagawa T., and Nakamura Y. Purification and some properties of recombinant sheep angiotensinogen expressed in Chinese hamster ovary cells. Biomed. Res. 18 (1997) 439-443
28. Gil D., Schrum A.G., Alarcón B., and Palmer Ed. T cell receptor engagement by peptide-MHC ligands induces a conformational change in the CD3 complex of thymocytes. J. Exp. Med. 201 (2005) 517-522
29. Gilbert J.M., Hernandez L.D., Balliet J.W., Bates P., and White J.M. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69 (1995) 7410-7415
30. Wei Y., Czekay R.P., Robillard L., Kugler M.C., Zhang F., Kim K.K., Xiong J., Humphries M.J., and Chapman H.A. Regulation of α5β1 integrin conformation and function by urokinase receptor binding. J. Cell Biol 168 (2005) 501-511
31. Feldt S., Batenburg W.W., Mazak I., Maschke U., Wellner M., Kvakan H., Dechend R., Fiebeler A., Burckle C., Contrepas A., Danser A.H.J., Bader M., Nguyen G., Luft F.C., and Muller D.N. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 51 (2008) 682-688
32. Feldt S., Maschke U., Dechend R., Luft F.C., and Muller D.N. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J. Am. Soc. Nephrol. 19 (2008) 743-748
33. Muller D.N., Klanke B., Feldt S., Cordasic N., Hartner A., Schmieder R.E., Luft F.C., and Hilgers K.F. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 51 (2008) 676-681
34. Methot D., Silversides D.W., and Reudelhuber T.L. In vivo enzymatic assay reveals catalytic activity of the human renin precursor in tissues. Circ. Res. 84 (1999) 1067-1072
35. Cumin F., Evin G., Fehrentz J.A., Seyer R., Castro B., Menard I., and Corvol P. Inhibition of human renin by synthetic peptides derived from its prosegment. J. Biol. Chem. 260 (1985) 9154-9157
36. Cousin C., Bracquart D., Contrepas A., Corvol P., Muller L., and Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53 (2009) 1077-1082